What it is
DSIP is a nonapeptide, a chain of nine amino acids, first isolated in 1977 from the cerebral venous blood of rabbits in induced slow-wave sleep. It was named for the state it was expected to produce, and that name is now the single most misleading thing about it.
What the controlled human research found
The compound was studied in humans through the 1980s in small controlled trials, and the results did not support the name.
The clearest test is Monti and colleagues, published in the International Journal of Clinical Pharmacology Research in 1987: a double-blind crossover trial in patients with chronic insomnia. Total sleep time and non-REM sleep did increase. But the increase came from stage 2, the lighter phase, while stage 1, slow-wave sleep (stages 3 and 4), and rapid-eye-movement sleep were not modified. The authors' own conclusion was that sleep improvement under DSIP treatment is of little clinical significance.
Slow-wave sleep is delta sleep. So the trial designed to test whether delta sleep-inducing peptide induces delta sleep reported that it did not, in the population most likely to show a benefit.
Other human work from the same period examined disturbed sleep and 24-hour sleep-wake behaviour with similarly modest results. The literature thins out after roughly 1992 and no large modern trial has revisited it.
Why the compound is still discussed
Two reasons, and they are worth separating.
The first is the name. A compound called delta sleep-inducing peptide markets itself, and vendor descriptions frequently restate the 1977 premise without reference to what the trials found.
The second is more legitimate. Research interest in DSIP did not centre only on sleep. It has been examined in stress response, pain modulation, and as a candidate neuroprotective and stress-adaptive agent, and those lines of enquiry do not depend on the sleep claim being correct. Anyone evaluating it should be clear about which body of work they are relying on.
How to read a listing for it
Descriptions that promise deeper or restorative sleep are asserting the specific outcome the controlled trials did not observe. That is the check worth applying here, and it is unusually easy to apply, because the compound's own name states the claim.
Vendors also vary widely on this one. Compare on price per milligram rather than on vial price, and look for third-party purity and identity testing before buying.